XML 29 R17.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Alan Russell  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On March 13, 2026, Alan Russell, Chief Scientific Officer and Director, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 200,000 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until July 1, 2027, or earlier if all transactions under the trading arrangement are completed.

Name Alan Russell
Title Chief Scientific Officer and Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 13, 2026
Aggregate Available 200,000
Expiration Date July 1, 2027